{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT03587961",
            "orgStudyIdInfo": {
                "id": "IRB-300001867"
            },
            "organization": {
                "fullName": "University of Alabama at Birmingham",
                "class": "OTHER"
            },
            "briefTitle": "Personalized Theratyping Trial",
            "officialTitle": "Personalized Theratyping Trial",
            "therapeuticArea": [
                "Other"
            ],
            "study": "personalized-theratyping-trial"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-09",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2019-08-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-09-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-01-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2018-07-03",
            "studyFirstSubmitQcDate": "2018-07-03",
            "studyFirstPostDateStruct": {
                "date": "2018-07-16",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-09-08",
            "lastUpdatePostDateStruct": {
                "date": "2023-09-11",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "George Solomon",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "University of Alabama at Birmingham"
            },
            "leadSponsor": {
                "name": "University of Alabama at Birmingham",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to explore the use of off-label CFTR modulators that may affect CFTR function in patients with CFTR mutations that are not currently approved for these drugs.",
            "detailedDescription": "The purpose of this study is to explore the use of off-label CFTR modulators that may affect CFTR function in patients with CFTR mutations that are not currently approved for these drugs. Symdeko (Tezacaftor/Ivacaftor), Orkambi (Ivacaftor and Lumacaftor), correctors of CFTR misfolding and Kalydeco (Ivacaftor), a potentiator of abnormal CFTR gating, will be explored as a treatment for patients with other CF mutations than those currently approved. Patients who have a mutation that responds to a CFTR corrector from in vitro study will be given Symdeko, or Orkambi, depending on the in vitro response pattern. Patients who have mutation response to a potentiator of CFTR function will be given Ivacaftor monotherapy. Patients with a mutation equivalent to wild type will be given Ivacaftor. If the patient is 6-12 years old, we will only study Orkambi or ivacaftor as symdeko is not yet FDA approved in this patient population."
        },
        "conditionsModule": {
            "conditions": [
                "Cystic Fibrosis"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "EARLY_PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 20,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Symdeko",
                    "type": "EXPERIMENTAL",
                    "description": "Patients who have a mutation that responds to a CFTR corrector from in vitro study will be given Symdeko, depending on the in vitro response pattern",
                    "interventionNames": [
                        "Drug: Symdeko"
                    ]
                },
                {
                    "label": "Ivacaftor",
                    "type": "EXPERIMENTAL",
                    "description": "Patients who have mutation response to a potentiator of CFTR function will be given Ivacaftor monotherapy.. Patients with a mutation equivalent to wild type will be given Ivacaftor.",
                    "interventionNames": [
                        "Drug: Symdeko"
                    ]
                },
                {
                    "label": "Orkambi",
                    "type": "EXPERIMENTAL",
                    "description": "Patients who have a mutation that responds to a CFTR corrector from in vitro study will be given Orkambi, depending on the in vitro response pattern",
                    "interventionNames": [
                        "Drug: Symdeko"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Symdeko",
                    "description": "explore the use of off-label CFTR modulators that may affect CFTR function in patients with CFTR mutations that are not currently approved for these drugs.",
                    "armGroupLabels": [
                        "Ivacaftor",
                        "Orkambi",
                        "Symdeko"
                    ],
                    "otherNames": [
                        "Orkambi",
                        "Ivacaftor"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "spirometry",
                    "description": "change in lung function as measured via spirometry",
                    "timeFrame": "32 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of CF\n* Age \u22656 y.o.\n* CFTR mutation that may respond to approved correctors/potentiators in the opinion of the study investigators\n* Informed Consent/Assent\n* Stable CF pulmonary regimen\n\nExclusion Criteria:\n\n* Exacerbation requiring antibiotic or steroids for \\>28 days before trial entry\n* Ongoing participation in a CFTR modulator study\n* Active smoking in the past 6 months\n* History of solid organ transplant\n* Any condition which precludes the use of CFTR modulators: e.g. advanced cirrhosis, End-stage Renal Disease (ESRD)\n* Any condition that precludes the patient from participation in the opinion of the investigator\n* Any meds that have significant drug-drug interactions or any other off label use of CFTR modulators",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "6 Years",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Heather Hathorne, PhD",
                    "role": "CONTACT",
                    "phone": "205-638-9568",
                    "email": "hhathorne@peds.uab.edu"
                }
            ],
            "locations": [
                {
                    "facility": "University of Alabama at Birmingham",
                    "status": "RECRUITING",
                    "city": "Birmingham",
                    "state": "Alabama",
                    "zip": "35233",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Heather Hathorne, PhD",
                            "role": "CONTACT",
                            "phone": "205-638-9568",
                            "email": "hhathorne@peds.uab.edu"
                        },
                        {
                            "name": "Ginger Reeves, BS",
                            "role": "CONTACT",
                            "phone": "205-638-5970",
                            "email": "greeves@peds.uab.edu"
                        },
                        {
                            "name": "George Solomon, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.52066,
                        "lon": -86.80249
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003550",
                    "term": "Cystic Fibrosis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000010182",
                    "term": "Pancreatic Diseases"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000007232",
                    "term": "Infant, Newborn, Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M6755",
                    "name": "Cystic Fibrosis",
                    "asFound": "Cystic Fibrosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8485",
                    "name": "Fibrosis",
                    "relevance": "LOW"
                },
                {
                    "id": "M13102",
                    "name": "Pancreatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M10276",
                    "name": "Infant, Newborn, Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T1710",
                    "name": "Cystic Fibrosis",
                    "asFound": "Cystic Fibrosis",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000545203",
                    "term": "Ivacaftor"
                }
            ],
            "ancestors": [
                {
                    "id": "D000065101",
                    "term": "Chloride Channel Agonists"
                },
                {
                    "id": "D000049990",
                    "term": "Membrane Transport Modulators"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M250281",
                    "name": "Ivacaftor",
                    "asFound": "Cross-sectional",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}